These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16571641

  • 1. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study.
    Platteau P, Andersen AN, Balen A, Devroey P, Sørensen P, Helmgaard L, Arce JC, Menopur Ovulation Induction (MOI) Study Group.
    Hum Reprod; 2006 Jul; 21(7):1798-804. PubMed ID: 16571641
    [Abstract] [Full Text] [Related]

  • 2. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
    Balen A, Platteau P, Andersen AN, Devroey P, Helmgaard L, Arce JC, Bravelle Ovulation Induction (BOI) Study Group.
    Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
    Andersen AN, Devroey P, Arce JC.
    Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
    [Abstract] [Full Text] [Related]

  • 4. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J, Andersen AN, Devroey P, Arce JC, MERIT Group.
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [Abstract] [Full Text] [Related]

  • 5. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study.
    Hugues JN, Cédrin-Durnerin I, Howles CM, FSH OI Study Group, Amram M, Angelini A, Balen A, Barbereau D, Birkhauser M, Boujenah A, De Leo V, De Placido G, Dessole S, Favrin S, Ferrazi E, Gay C, Germond M, Hedon B, Hocke C, Jolly C, Lamarca-Roth E, Lanzone A, Marchand F, Marcolin G, Mascaretti G, Moreau L, Massobrio M, Nappi C, Pardi G, Pennehouat G, Porcu E, Seibert M, Selvaggi L, Thiers D, Venturini P.
    Hum Reprod; 2006 Nov; 21(11):2817-22. PubMed ID: 16877376
    [Abstract] [Full Text] [Related]

  • 6. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF.
    Ziebe S, Lundin K, Janssens R, Helmgaard L, Arce JC, MERIT (Menotrophin vs Recombinant FSH in vitro Fertilisation Trial) Group.
    Hum Reprod; 2007 Sep; 22(9):2404-13. PubMed ID: 17640944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
    Witz CA, Daftary GS, Doody KJ, Park JK, Seifu Y, Yankov VI, Heiser PW, Menopur in GnRH Antagonist Cycles with Single Embryo Transfer – High Responder (MEGASET-HR) Trial Group.
    Fertil Steril; 2020 Aug; 114(2):321-330. PubMed ID: 32416978
    [Abstract] [Full Text] [Related]

  • 9. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
    Ye H, Huang G, Pei L, Zeng P, Luo X.
    Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [Abstract] [Full Text] [Related]

  • 11. Exogenous hCG activity, but not endogenous LH activity, is positively associated with live birth rates in anovulatory infertility.
    Arce JC, Smitz J.
    Hum Fertil (Camb); 2011 Sep; 14(3):192-9. PubMed ID: 21732905
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG, Broekmans FJ, Hoozemans DA, Schats R, FIRM group.
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [Abstract] [Full Text] [Related]

  • 13. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
    Kocak M, Dilbaz B, Demir B, Taşci Y, Tarcan A, Dede S, Haberal A.
    Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
    [Abstract] [Full Text] [Related]

  • 14. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
    Balen AH, Platteau P, Andersen AN, Devroey P, Sørensen P, Helmgaard L, Arce JC.
    BJOG; 2006 Oct; 113(10):1195-202. PubMed ID: 16903840
    [Abstract] [Full Text] [Related]

  • 15. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
    Demirol A, Gurgan T.
    Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T, Kremer JA, Cohlen BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, van Dop PA.
    Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
    [Abstract] [Full Text] [Related]

  • 19. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
    Gomes MK, Vieira CS, Moura MD, Manetta LA, Leite SP, Reis RM, Ferriani RA.
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
    [Abstract] [Full Text] [Related]

  • 20. Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone.
    Leader A, Monofollicular Ovulation Induction Study Group.
    Fertil Steril; 2006 Jun; 85(6):1766-73. PubMed ID: 16759926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.